AgeTech Recommendation
TOTAL SCORE: 10
Score
A1 (Feasibility increased by continuance of pandemic): +1
A2 (Necessity increased by covid pandemic): +1
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): 0
C1 (Market readiness applicability): +1
C2 (Project readiness): +1
C3 (Move to market readiness): +1
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): 0
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): 0
E (Disruptiveness): 0
F (Dividends - does the recommendation aid in social activity and inclusivity?): +1
Point of comparison: The Committee’s recommendation is in complete accordance with Aging Analytics Agency’s belief that AgeTech is a necessary component in everything from reduction in loneliness to keeping the elderly demographic economically, socially and professionally active, and that UK funding and support of its domestic AgeTech Industry be prioritized considering it’s already-substantial size, high degree of market -readiness, and potential to have accelerated and efficient short-term impacts on the quality of life of the UK’s elderly population. However, it should be emphasised that the UK is already a world leader in AgeTech, and that forms of AgeTech may play a necessary early role in biomarker development. For a comprehensive overview of the UK AgeTech industry visit Aging Analytics Agency’s AgeTech UK IT Platform.
RECOMMENDATION SUMMARY
Aging Analytics Agency’s position is that there are many such specific UK issues and challenges of national importance that we believe AgeTech has the potential to substantially impact include alleviating the economic burden of the nation's ageing population, protection and treatment of COVID-19 in the elderly, social isolation, loneliness and mental health, increased economic activity and participation among the 60+ demographic, and much-needed reforms to care homes and social care among the nation’s elderly. We would refer the Committee to Aging Analytics Agency's AgeTech Analytics Platform.
Score
A1 (Feasibility increased by continuance of pandemic): +1
A2 (Necessity increased by covid pandemic): +1
A3 (political viability): +1
B1 (Relevance to the specific goal of increasing HALE by 5 years by 2035): +1
B2 (Relevance to general goal of biomedical healthy life extension): 0
C1 (Market readiness applicability): +1
C2 (Project readiness): +1
C3 (Move to market readiness): +1
D1 (Actionability): 0
D2 (Degree of measurability): 0
D3 (Degree of leveraging cross-sector inputs): 0
D4 (Awareness of international context): +1
D5 (Resourcefulness): +1
D6 (Reorganisation): 0
E (Disruptiveness): 0
F (Dividends - does the recommendation aid in social activity and inclusivity?): +1
Point of comparison: The Committee’s recommendation is in complete accordance with Aging Analytics Agency’s belief that AgeTech is a necessary component in everything from reduction in loneliness to keeping the elderly demographic economically, socially and professionally active, and that UK funding and support of its domestic AgeTech Industry be prioritized considering it’s already-substantial size, high degree of market -readiness, and potential to have accelerated and efficient short-term impacts on the quality of life of the UK’s elderly population. However, it should be emphasised that the UK is already a world leader in AgeTech, and that forms of AgeTech may play a necessary early role in biomarker development. For a comprehensive overview of the UK AgeTech industry visit Aging Analytics Agency’s AgeTech UK IT Platform.
RECOMMENDATION SUMMARY
Aging Analytics Agency’s position is that there are many such specific UK issues and challenges of national importance that we believe AgeTech has the potential to substantially impact include alleviating the economic burden of the nation's ageing population, protection and treatment of COVID-19 in the elderly, social isolation, loneliness and mental health, increased economic activity and participation among the 60+ demographic, and much-needed reforms to care homes and social care among the nation’s elderly. We would refer the Committee to Aging Analytics Agency's AgeTech Analytics Platform.